Probing the skin permeation of fish oil/EPA and ketoprofen-3. Effects on epidermal COX-2 and LOX

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 6, 2007, Pages 357-362

  Thomas, Christopher P ^a   Davison, Zoe ^a   Heard, Charles M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOOTS SUPER STRENGTH; CYCLOOXYGENASE 2; FISH OIL; ICOSAPENTAENOIC ACID; KETOPROFEN; LIPOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN PERMEABILITY; SKINFOLD THICKNESS;

ADMINISTRATION, TOPICAL; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; EAR, EXTERNAL; ENZYME ACTIVATION; EPIDERMIS; FISH OILS; IMMUNOHISTOCHEMISTRY; KETOPROFEN; LIPOXYGENASE; ORGAN CULTURE TECHNIQUES; PERMEABILITY; SKIN ABSORPTION; SWINE;

SUS;

EID: 34447631317     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.05.002     Document Type: Article

References (18)

1. Hotchkiss S.A.M. Dermal metabolism. In: Roberts M.S., and Walters K.A. (Eds). Dermal Absorption and Toxicity Assessment (1998), Marcel Decker, New York
2. Heard C.M., Gallagher S.J., Harwood J.L., and Maguire P.B. The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle-evidence that solutes permeate skin associated with their solvation cages?. Int. J. Pharm. 261 (2003) 165-169
3. Thomas C.P., and Heard C.M. In vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a fish oil vehicle incorporating 1,8-cineole. Drug Delivery 12 (2005) 7-14
4. Puglia C., Tropea S., Rizza L., Santagati N.A., and Bonina F. In vitro percutaneous absorption studies and in vivo evaluation of anti-inflammatory activity of essential fatty acids (EFA) from fish oil extracts. Int. J. Pharm. 299 (2005) 41-48
5. C.P. Thomas, J. Platts, T. Tatchell, C.M. Heard, Probing the skin permeation of fish oil/EPA and ketoprofen 1. NMR spectroscopy and molecular modelling, Int. J. Pharm., submitted not yet accepted.
6. C.P. Thomas, C.M. Heard, Probing the skin permeation of fish oil/EPA and ketoprofen 2. Comparative depth profiling and metabolism of eicosapentaenoic acid, Eur. J. Pharm. Biopharm., in press.
7. Leung D.Y.M., Szfler S.J., Noman P.S., Apter A., Eichenfield L.F., and Beck L. Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis. J. Allergy Clin. Immunol. 111 (2003) 1154-1168
8. Stone O.J. Psoriasis: highly reactive early cellular inflammation. Med. Hypotheses 31 (1990) 47-53
9. Mueller M.M. Inflammation in epithelial skin tumours: old stories and new ideas. Eur. J. Cancer 42 (2006) 735-744
10. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 72 (2006) 1605-1621
11. Abou-Raya A., and Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun. Rev. 5 (2006) 331-337
12. Athar M., An K.P., Morel K.D., Kim Al., Aszterbaum M., Longley J., Epstein E.H., and Bickers J.R. Ultraviolet B (UVB)-induced COX-2 expression in murine skin: an immunohistochemical study. Biochem. Biophys. Res. Commun. 280 (2001) 1042-1047
13. Gonzalez A.L., Robert R.L., Massion P.P., Olson S.J., Shyr Y., and Shappell S.D. 15-lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumour grade and proliferation. Human Pathol. 35 (2004) 840-849
14. Lee J.L., Mukhtar H., Bickers D.R., Kopelovich L., and Athar M. Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol. Appl. Pharmacol. 192 (2003) 294-306
15. Brain S.D., and Williams T.J. Leukotrienes and inflammation. Pharmacol. Therap. 46 (1990) 57-66
16. 〈http://www.cellsignal.com/product.asp?catalog%5Fname=CellSignal&category%5Fname=&product%5Fid=4842〉 (accessed 10 December 2006).
17. Miller C.C., and Ziboh Z.A. Human epidermis transforms eicosapentaenoic acid to 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid-a potent inhibitor of 5-lipoxygenase. J. Am. Oil Chem. Soc. 65 (1988) 474-474
18. Serhan C.N., Gotlinger K., Hong S., and Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediators 73 3-4 (2004) 155-172